IRIC presents the 41st edition of its scientific lecture series—Fall 2026.
Join us to hear renowned leading researchers from Canada, the United States, and Europe present their latest scientific breakthroughs.
Please note that the lectures will be held in person on Mondays from 11:30 a.m. to 12:30 p.m. in Room S1-151 of the Jean-Coutu Pavilion, 2950 Chemin de Polytechnique.
11:30 a.m. to 12:30 p.m.
Lectures in English
Free admission
SEPT 14
Cédric Tremblay | University of Manitoba, Winnipeg, MB, CA
Beyond Therapy Resistance: Cracking the Blueprint of Leukemia Relapse
Beyond Therapy Resistance: Cracking the Blueprint of Leukemia Relapse
SEPT 21
Ivan Topisirovic | McGill University, Montreal, QC, CA
Translational Rheostat Drives Breast Cancer Metastasis
Translational Rheostat Drives Breast Cancer Metastasis
SEPT 28
Nagarajan Vaidehi | Beckman Research Institute, Duarte-Los Angeles, CA, US
Interpretable AI For Uncovering Cooperativity and Allostery in Proteins
Interpretable AI For Uncovering Cooperativity and Allostery in Proteins
OCT 5
Michel Salzet | Université de Lille, FR
Ghost in the Cell and Therapies in Cancer
Ghost in the Cell and Therapies in Cancer
OCT 19
Jakob Nilsson | Danish Cancer Institute, Copenhague, DK
Regulation and Substrate Specificity of PP2A-like Protein Phosphatases
Regulation and Substrate Specificity of PP2A-like Protein Phosphatases
OCT 26
Miriam Carolin Stoeber | Université de Genève, Genève, CH
Probing and Modulating GPCR Function with Subcellular Resolution
Probing and Modulating GPCR Function with Subcellular Resolution
NOV 2
Mélanie Laurin | Université Laval, Quebec, QC, CA
From Cells to Patterns: How Rho GTPases Shape Skin Organization During Embryonic Development
From Cells to Patterns: How Rho GTPases Shape Skin Organization During Embryonic Development
NOV 9
Sylvie Mader | IRIC, Université de Montréal, Montreal, QC, CA
Understanding the Mechanisms of Action of Cancer Therapeutic Agents to Improve Patient Outcomes
Understanding the Mechanisms of Action of Cancer Therapeutic Agents to Improve Patient Outcomes
NOV 16
Norman Iscove | University of Toronto, Toronto, ON, CA
Self-Renewal as a Master Vulnerability Spanning Diverse Myeloproliferative/leukemic Disorders
Self-Renewal as a Master Vulnerability Spanning Diverse Myeloproliferative/leukemic Disorders
NOV 23
Yoshiaki Tanaka | HMR – Université de Montréal, Montreal, QC, CA
Application of Brain Tumor Organoid for Drug Testing
Application of Brain Tumor Organoid for Drug Testing
NOV 30
Lynne-Marie Postovit | Queen’s University, Kingston, ON, CA
Mechanisms Underpinning Cellular Plasticity in Cancer
Mechanisms Underpinning Cellular Plasticity in Cancer
DEC 7
Simon Gaudreau | Immune Biosolutions, Université de Sherbrooke, Sherbrooke, QC, CA To be announced
DEC 14
Gerardo Ferbeyre | Université de Montréal, Montreal, QC, CA
Chromatin Opening Drives Commitment to Senescence
Chromatin Opening Drives Commitment to Senescence